No abstract available
Keywords:
HIF; VEGF; VEGFR; angiogenesis; cancer; hypoxia; signaling pathways.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Editorial on the Research Topic Hypoxia and angiogenesis in cancer
References
-
-
Heer E. C., Jalving M., Harris A. L. (2020). HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J. Clin. Invest. 130 (10), 5074–5087. 10.1172/jci137552
-
DOI
-
PMC
-
PubMed
-
-
Malekan M., Ebrahimzadeh M. A., Sheida F. (2021). The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma. Biomed. Pharmacother. 141, 111873. 10.1016/j.biopha.2021.111873
-
DOI
-
PubMed
-
-
Malekan M., Haass N. K., Rokni G. R., Gholizadeh N., Ebrahimzadeh M. A., Kazeminejad A. (2024). VEGF/VEGFR axis and its signaling in melanoma: current knowledge toward therapeutic targeting agents and future perspectives. Life Sci. 345, 122563. 10.1016/j.lfs.2024.122563
-
DOI
-
PubMed
-
-
Yuan S., Almagro J., Fuchs E. (2024). Beyond genetics: driving cancer with the tumour microenvironment behind the wheel. Nat. Rev. Cancer 24 (4), 274–286. 10.1038/s41568-023-00660-9
-
DOI
-
PMC
-
PubMed